Clinical Cases in Glaucoma Treatment

Slides:



Advertisements
Similar presentations
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Advertisements

Will my Glaucoma patient lose vision ?
RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.
South Hills Eye Associates
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
The Royal Victorian Eye and Ear Hospital 24-hour eye pressure and glaucoma Dr Simon Skalicky FRANZCO, MPhil, MMed (Ophthal Sci), MBBS (Hons 1) Visiting.
CLASS™ by IOPtima Better & Safer Glaucoma Surgery Are you diagnosed with Glaucoma? Would you like to maintain your sight? Are you tired of applying medications?
Upfront Combination Therapy vs Step-Up Approach for PAH:
The Patient Experience With Systemic Lupus Erythematosus
Glaucoma.
nAMD: Choosing the Best Treatment for your Patient
Diabetic Dyslipidemia in Practice
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Making Decisions With Your Osteoarthritis Patients
Gout Management.
A Paradigm Shift in PAH.
Goals of Therapy for Patients With UC
Glaucoma Progression.
Progression After Cancer Immunotherapy in Advanced NSCLC
MANAGING GLAUCOMA:.
Motor Fluctuations in Parkinson Disease: Options and Strategies
What Predicts Disability Progression in Multiple Sclerosis?
Modern Strategies for Basal Insulin Use in T2D
Ask the Onychomycosis Expert, Part 2
The Latest Data on Oral Prostacyclin Therapy in PAH
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Individualizing Prophylaxis in Hemophilia
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Continuing the Advances in Relapsed/Refractory CLL: New Data, New Paradigms.
Optimizing Outcomes in the Management of GIST
Comparing Treatment Alternatives in Ankylosing Spondylitis
Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.
nAMD: Switching Therapies - what you need to know
Time to Take Gout Seriously
Glaucoma: Detect, Diagnose, And Monitor The Silent Thief of Vision
The future of urate-lowering strategies for gout
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Consensus on Glaucoma Control
Gene Therapy: Past, Present, and Future
Managing Adverse Events With New Oral Therapies in CLL
Immunotherapy for cSCC
Advancing the Treatment of IBD With Biologics
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Treating to Target in MS
When Is Biologic Therapy Appropriate for HS?
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Intro: Biomarkers in RA
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
nAMD: Choosing the Best Treatment for your Patient
Atopic Dermatitis in the Pediatric Practice
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient Questions and Expert Answers in Psoriasis:
A Guideline-Based Approach to HCV Care
Are We Making Progress in the Management of Huntington Disease?
Optimizing Treatment in HR-Positive Breast Cancer: A Case-Based Discussion.
Challenges in LA SCCHN.
Novel Concepts in the Management of RCC
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
The Patient With Early Stage MF-CTCL
When Good Isn't Good Enough
Program Goals Overview Is NEDA a Reasonable Target?
Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Third-Generation EGFR TKIs
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
MS, Age, and Immune Function
Ask the Psoriasis Expert
Motor Fluctuations in PD
Presentation transcript:

Clinical Cases in Glaucoma Treatment

Program Overview: Patient Cases

Patient Case 1

Personalizing and Optimizing Glaucoma Therapy: General Principles

Setting Individual IOP Ranges

Different Circumstances That Lead to the Decision for Surgical Intervention

Maximal Pressure Lowering Minimizes Progression

How Would This Patient’s Treatment Approach Be Different in South America?

Surgical Options for Treating Patients With Advanced Glaucoma

Comparison of Outflow Procedures Currently Available

Patient Case 2

Patient Optic Nerves Show Damage

Distinguishing Advanced Glaucoma

Monitoring Patients With Advanced Glaucoma Can Be Difficult

Patient Case 2: Target Pressure Range

Treatment Options to Achieve Very Low Target IOP

Practice Patterns in Europe, UK, and US Using Fixed Combination Therapy

Fixed Combination (Brinzolamide/Brimonidine) Lowers IOP by 21%-35% From Baseline at Month 3

Wipe-Out Phenomenon: Losing Central Vision in Patients With Advanced Disease

Moorfields Safer Surgery System: Minimizing the Risk of Complications

Patient Case 3

Adherence to Glaucoma Therapy

Patient Case 3: Alternatives to Patient-Administered Therapy

Patient Case 3: SLT Monotherapy

Concluding Remarks

Abbreviations

Abbreviations (cont)